Maternal and Fetal Outcome in Placenta Accreta Spectrum (PAS): A prospective Study At Minia University Maternity Hospital

Aim:This study aimed to evaluate maternal and fetal outcome in placenta accreta spectrum cases at Minia University Maternity hospital. Methods:prospective study was conducted in Minia University Maternity hospital in the period between June 2024 till February 2025.Study included 100 patients Outcome measures:Maternal outcome measures included:Estimated blood loss,Amount of blood transfusion,Mode of delivery,Complications,pre and postoperative,hemoglobin level,ICU admission,Neonatal outcome measures included:Neonatal weight,APGAR score,Prematurity,NICU admission,IUFD. Results:showed that,75% of cases had Placenta accreta,17% of cases had Placenta increta,and 8% of cases had Placenta percreta.mean of hemoglobin (pre) was 11.13 ±1.33 g/dl with range 11.3 (7.5-14),mean of Visual assessment of blood loss was 1417.5 ±570.81 cc,with range 1500 (750-300), mean of Blood transfusion was 3.08 ±1.5 units with range 3 (1-10) , and mean of hemoglobin( post ) was 8.97 ±1.8 g/dl with range( 5 - 12.7) , 14% of cases entered ICU, while 86% of cases entered HDU, no cases were dead, 4% of cases required Ventilatory support, 10% of cases required Hemodynamic support, 13% of cases preformed Primary Cs hysterectomy, 5 % performed secondary Cs hysterectomy , 11% of cases had Postpartum hemorrhage, 18% of cases had UB injury, and 2% of cases had Acute kidney injury. Conclusion: placenta previa has higher incidence rate with increasing number of previous caesarean section deliveries. Placenta previa patients at risk of maternal and neonatal morbidities,maternal morbidities include life threatening haemorrhage, caesarean hysterectomy, blood transfusion, and ICU admission. Neonatal morbidities include premature delivery, low birth weight, intrauterine fetal death and NICU admission.